Elab Fluor ® 647 Anti-Human CD68 Antibody[Y1/82A] (E-AB-F1299M) elabscience

$240.00
In stock
SKU
E-AB-F1299M
SizePrice (USD)
100Tests$240.00
20Tests$89.00
100Tests×2$360.00

Product Details

AbbreCD68
SynonymsMacrosialin
SwissprotP34810
ReactivityHuman
HostMouse
ClonalityMonoclonal
CloneY1/82A
IsotypeMouse IgG2b, κ
Isotype ControlElab Fluor ® 647 Mouse IgG2b, κ Isotype Control[MPC-11]
ApplicationsICFCM
ConjugationElab Fluor ® 647
Concentration5 μL/Test
BufferPhosphate buffered solution, pH 7.2, containing 0.09% stabilizer.
Research AreasCell Biology, Immunology, Neuroscience, Neuroscience Cell Markers
Cellular LocalizationMembrane;Cytoplasm

Product Description

Conjugation Information: Elab Fluor ® 647 is designed to be excited by the Red laser (627-640 nm) and detected using an optical filter centered near 670 nm (e.g., a 660/20 nm bandpass filter).

Background: CD68 is a 110 kD glycoprotein, also known as macrosialin, belonging to the sialomucin family. It is closely related to the family of acidic, highly glycosylated lysosomal-associated membrane proteins (LAMPs). CD68 is predominately expressed in cytoplasmic granules of monocytes/macrophages, dendritic cells, and granulocytes. It is one of the useful myeloid cell markers. Further studies have shown that CD68 is also expressed by a subset of hematopoietic progenitors, γ/δ T cells, NK cells, LAK cells, subset of B cells, fibroblasts, and endothelial cells. The biological function of CD68 is still unknown.

Storage and Shipping

StorageThis product can be stored at 2-8°C for 24 months. Please protected from prolonged exposure to light and do not freeze.
ShippingIce bag
  1. Fungal metabolite-based immunotherapy overcomes tumor-associated macrophage immunosuppression
    Journal: Cell Reports Medicine | Year: 2026 | Impact Factor: 14.000
    DOI: 10.1016/j.xcrm.2026.102833 | Reactivity: Human, Mouse | Sample Type: BM-derived macrophages (BMDMs)
  2. Targeting the FBXW7-AKAP13-YAP axis suppresses gliomagenesis by dual inhibition of tumor invasion and macrophage recruitment
    Journal: BIOCHEMICAL PHARMACOLOGY | Year: 2026 | Impact Factor: 5.600
    DOI: 10.1016/j.bcp.2026.117677 | Reactivity: Human | Sample Type: THP-1 cell
  3. HMGA2 promotes hepatocellular carcinoma progression by regulating tumor-associated macrophage via Notch1/CCL2 signaling
    Journal: MOLECULAR AND CELLULAR BIOCHEMISTRY | Year: 2026 | Impact Factor: 3.700
    DOI: 10.1007/s11010-026-05491-4 | Reactivity: Human | Sample Type: HepG2 cell
  4. SIGLEC6 impairs trophoblast function and orchestrates macrophage M1 polarization via suppression of Akt signaling in early-onset preeclampsia
    Journal: PLACENTA | Year: 2026 | Impact Factor: 3.100
    DOI: 10.1016/j.placenta.2026.05.107 | Reactivity: Human
  5. Synovium-On-A-Chip: Simulating the Microenvironment of the Rheumatoid Arthritis Synovium via Multicell Interactions to Target Fibroblast-Like Synoviocytes
    Journal: Advanced Science | Year: 2025 | Impact Factor: 14.100
    DOI: 10.1002/advs.202511945 | Reactivity: Human | Sample Type: Fibroblast-like synoviocytes,THP-1 cell,human umbilical vein endothelial cell
  6. Dimethyl itaconate suppresses dendritic cell and CD8+ T cell responses to halt vitiligo
    Journal: BMC Medicine | Year: 2025 | Impact Factor: 8.300
    DOI: 10.1186/s12916-025-04512-1 | Reactivity: Human, Mouse | Sample Type: Serum
  7. 15-Deoxy-Δ-12,14-Prostaglandin J2 Represses Immune Escape of Lung Adenocarcinoma by Polarizing Macrophages Through Epidermal Growth Factor Receptor/Ras/Raf Pathway
    Journal: JOURNAL OF IMMUNOTHERAPY | Year: 2024 | Impact Factor: 3.200
    DOI: 10.1097/CJI.0000000000000546 | Reactivity: Human | Sample Type: A549 cell,CD8+ T cell,macrophage
  8. Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages
    Journal: Heliyon | Year: 2023 | Impact Factor: 4.000
    DOI: 10.1016/j.heliyon.2023.e14272 | Reactivity: Human

Reviews

Write Your Own Review
You're reviewing:Elab Fluor ® 647 Anti-Human CD68 Antibody[Y1/82A] (E-AB-F1299M) elabscience
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.